1. BLT received US$161,674 dividend from Tacere in 2010. 2. BLT own 5% of Tacere 3. Pfizer is paying upto $145 Tacere for Hepatitis C program
Tacere announced: In preclinical animal studies, we have demonstrated that a single intravenous injection of our agent results in penetration of hepatocytes (the site of HCV replication) at sufficiently high levels to potentially eradicate HCV. After years of developing this ?cocktail in one drug?, it is incredibly satisfying to see our efforts rewarded and expectations exceeded.?
